THE SPECTRUM OF MOLECULAR ALTERATIONS IN THE EVOLUTION OF CHRONIC MYELOCYTIC-LEUKEMIA

被引:175
作者
AHUJA, H
BARELI, M
ARLIN, Z
ADVANI, S
ALLEN, SL
GOLDMAN, J
SNYDER, D
FOTI, A
CLINE, M
机构
[1] UNIV CALIF LOS ANGELES,CTR CANC,DIV HEMATOL ONCOL,LOS ANGELES,CA 90024
[2] NEW YORK MED COLL,VALHALLA,NY 10595
[3] CORNELL UNIV,N SHORE UNIV HOSP,MED CTR,MANHASSET,NY 11030
[4] TATA MEM HOSP,BOMBAY,INDIA
[5] HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,LONDON W12 0HS,ENGLAND
[6] CITY HOPE NATL MED CTR,DUARTE,CA 91010
关键词
P53; N-RAS; CML; BLAST CRISIS; MUTATIONS;
D O I
10.1172/JCI115234
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
DNA from 135 patients with chronic myelogenous leukemia (CML) at various clinical stages and Philadelphia (Ph1) chromosome positive acute lymphoblastic leukemia was investigated for alterations in a variety of proto-oncogenes which have been implicated in the evolution of CML from its chronic phase to blast crisis. The most common genetic change found in the evolution of typical Ph1 chromosome positive CML to blast crisis was an alteration of the p53 gene involving either a rearrangement, a deletion, or a point mutation in the coding sequence of the gene. Alterations of the p53 gene were found in the myeloid and the rare megakaryocytic variant of blast crisis but were absent in the lymphoid leukemic transformants. Gross structural alterations were seen in 11 of 54 (20%) of myeloid or unknown phenotypes of blast crisis and in only 1 of 44 chronic phase cases. Eight examples of mutations in the open reading frame of the p53 gene at codons 49, 53, 60, 140, 202, 204, 238, and 239 were observed in blast crisis patients. Mutations in the N-RAS gene were rare in typical blast crisis (2 of 27 cases) but were found in megakaryocytic and Ph1 negative myeloid blast crisis. We concluded that heterogeneous alterations in the p53 gene and occasionally in the N-RAS genes accompany the evolution of chronic phase CML to blast crisis.
引用
收藏
页码:2042 / 2047
页数:6
相关论文
共 43 条
[1]  
AHUJA H, 1989, CANCER CEL, V7, P117
[2]   ALTERATIONS IN THE P53 GENE AND THE CLONAL EVOLUTION OF THE BLAST CRISIS OF CHRONIC MYELOCYTIC-LEUKEMIA [J].
AHUJA, H ;
BARELI, M ;
ADVANI, SH ;
BENCHIMOL, S ;
CLINE, MJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (17) :6783-6787
[3]  
AHUJA HG, 1990, BLOOD, V75, P1684
[4]  
AHUJA HG, 1990, BLOOD, P1819
[5]   CHROMOSOME-17 DELETIONS AND P53 GENE-MUTATIONS IN COLORECTAL CARCINOMAS [J].
BAKER, SJ ;
FEARON, ER ;
NIGRO, JM ;
HAMILTON, SR ;
PREISINGER, AC ;
JESSUP, JM ;
VANTUINEN, P ;
LEDBETTER, DH ;
BARKER, DF ;
NAKAMURA, Y ;
WHITE, R ;
VOGELSTEIN, B .
SCIENCE, 1989, 244 (4901) :217-221
[6]  
BARELI M, 1989, BLOOD, V73, P281
[7]   TRANSLOCATION OF C-ABL ONCOGENE CORRELATES WITH THE PRESENCE OF A PHILADELPHIA-CHROMOSOME IN CHRONIC MYELOCYTIC-LEUKEMIA [J].
BARTRAM, CR ;
DEKLEIN, A ;
HAGEMEIJER, A ;
VANAGTHOVEN, T ;
VANKESSEL, AG ;
BOOTSMA, D ;
GROSVELD, G ;
FERGUSONSMITH, MA ;
DAVIES, T ;
STONE, M ;
HEISTERKAMP, N ;
STEPHENSON, JR ;
GROFFEN, J .
NATURE, 1983, 306 (5940) :277-280
[8]   THE CHRONIC MYELOGENOUS LEUKEMIA SPECIFIC P210-PROTEIN IS THE PRODUCT OF THE BCR/ABL HYBRID GENE [J].
BEN-NERIAH, Y ;
DALEY, GQ ;
MESMASSON, AM ;
WITTE, ON ;
BALTIMORE, D .
SCIENCE, 1986, 233 (4760) :212-214
[9]  
BOS JL, 1987, BLOOD, V69, P1237
[10]   UNIQUE FORMS OF THE ABL TYROSINE KINASE DISTINGUISH PH1-POSITIVE CML FROM PH1-POSITIVE ALL [J].
CLARK, SS ;
MCLAUGHLIN, J ;
CRIST, WM ;
CHAMPLIN, R ;
WITTE, ON .
SCIENCE, 1987, 235 (4784) :85-88